---
title: "Fluoxymesterone - Noonan Syndrome - 2"
sidebar: mydoc_sidebar
permalink: db01185-mesh-d009634-2.html
toc: false 
---


Path ID: `DB01185_MESH_D009634_2`
{% include image.html url="images/db01185-mesh-d009634-2.png" file="db01185-mesh-d009634-2.png" alt="db01185-mesh-d009634-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D005474 | Fluoxymesterone | Drug |
| UniProt:P10275 | Androgen receptor | Protein |
| GO:0030521 | Androgen receptor signaling pathway | BiologicalProcess |
| GO:0046544 | Development of secondary male sexual characteristics | BiologicalProcess |
| MESH:D009634 | Noonan syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Fluoxymesterone | INCREASES ACTIVITY OF | Androgen Receptor |
| Androgen Receptor | POSITIVELY REGULATES | Androgen Receptor Signaling Pathway |
| Androgen Receptor Signaling Pathway | POSITIVELY CORRELATED WITH | Development Of Secondary Male Sexual Characteristics |
| Development Of Secondary Male Sexual Characteristics | NEGATIVELY CORRELATED WITH | Noonan Syndrome |
|---------|-----------|---------|

Comment: Fluoxymesterone is a synthetic androgen, or male hormone, similar to testosterone. No clear mechanism of action is found in literature evidences.

Reference: 
  - [https://go.drugbank.com/drugs/DB01185](https://go.drugbank.com/drugs/DB01185)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1049925/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1049925/)
